Andrew Mizisin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$4.1MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $4.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 9, 2019 | NIH | STTR Phase II Development of Pirenzepine for CIPN | $1.4M | WinSanTor, Inc. |
| Sep 20, 2018 | NIH | STTR Phase II Development of Pirenzepine for CIPN | $2.0M | WinSanTor, Inc. with UNIVERSITY OF CALIFORNIA, SAN DIEGO |
| Sep 18, 2017 | NIH | STTR Phase I Development of Pirenzepine for HIV-SN | $466K | WinSanTor, Inc. |
| May 23, 2017 | NIH | STTR Phase I Development of Pirenzepine for CIPN | $299K | WinSanTor, Inc. |
Peer ranks
Federal funding#372
Awards as PI#566
Patents#273
Companies
- WinSanTor, Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.